Semaglutide currently not cost-effective for heart patients without diabetes, study finds
For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, ...
来自MSN33 分钟
Younger cancer survivors 11 times more likely to die prematurely years later: U of C study
Younger cancer survivors, even after successful treatment, are 11.4 times more likely to die an early death than those in the ...